Tkach T, Li E, Bestagno M, Burrone O R
International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Immunol Lett. 1996 Sep;52(2-3):81-7. doi: 10.1016/0165-2478(96)02588-6.
Different splice variants of the CD44 cell-surface molecule have been linked to metastasis formation in several animal and human cancers. We have used metastatic CSML-100 and non-metastatic CSML-0 mouse adenocarcinoma cell lines to determine whether variant CD44 molecules could be implicated in the different behaviour of these cells. Two CD44 splice variants containing exons v7-v10 and v8-v10 were detected in the non-metastatic CSML-0. Two other mouse cell lines, the normal mammary gland NMuMG and the mammary pre-neoplastic CL-S1 were also found to express these exons. A short (hematopoietic) CD44 isoform was expressed in the metastatic CSML-100 and three other mouse mammary tumour cell lines. Overexpression of v7-v10 and v8-v10 CD44 variants in CSML 100 cells did not decrease their metastatic potential.
CD44细胞表面分子的不同剪接变体已与多种动物和人类癌症的转移形成相关联。我们使用转移性CSML-100和非转移性CSML-0小鼠腺癌细胞系来确定变体CD44分子是否与这些细胞的不同行为有关。在非转移性CSML-0中检测到两个包含外显子v7-v10和v8-v10的CD44剪接变体。另外两个小鼠细胞系,正常乳腺NMuMG和乳腺肿瘤前体CL-S1也被发现表达这些外显子。一种短的(造血)CD44异构体在转移性CSML-100和其他三种小鼠乳腺肿瘤细胞系中表达。CSML 100细胞中v7-v10和v8-v10 CD44变体的过表达并未降低其转移潜力。